ERBB2 and breast carcinoma: For instance, while breast cancer tumors of the normal-like and basal subtypes, and their corresponding normal tissues align in NMD efficiency, the other breast cancer subtypes HER2, Luminal A, and Luminal B display higher iNMDeff; this is consistent with reports of higher UPF1 expression in these subtypes [39].